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Silmmary 
Several recent observations suggest that successful rearrangement of the T cell receptor (TCR) 
B locus reduces several important events in thymocyte maturation. Allelic exclusion is achieved 
by interruption of further rearrangement of the ~/locus, and CD4-8-  mterleukln (IL)-2R + 
cells enter the CD4 +8 +  IL-2R-  stage. The actual molecular events regnlatmg this important 
control point are unknown, but may be related to the expression of the TCR-B locus in immature 
CD4-8-  thymocytes. It is not clear whether maturation is induced by intracellular appearance 
of TCR-B chain or by signal transductlon through an immature TCR complex on the thymocyte 
membrane, possibly involving TCR-/~ chain homodimers and CD3. Here we show that early 
ad&tion of anti-CD3 mAb to fetal thymic organ cultures induces all known events associated 
with the acqmsitlon of the CD4 +  8 + stage. Expression of CD4 and CD8 is accelerated, IL-2RoL 
is downregnlated, and the cells fail to produce TCR-B, possibly based on premature cessation 
of  ~ gene rearrangement. Upon stimulation with anti-CD3 antibodies, we see calcinm mobilization 
m 15% of all CD4-8-  thymocytes with no detectable surface TCR expression. These results 
suggest that functional CD3 is expressed on immature thymocytes at very low concentrations 
before the appearance of a complete TCR-~/chain. Llgation of CD3 at this stage may mimic 
the maturauon signal normally generated by the immature TCR-B homochmer-CD3 complex. 
The results are consistent with the notion that acquisition of the CD4+8 + stage involves signal 
transduction through an immature TCR complex.  Later in thymocyte development,  ligatlon 
of CD3 results in deleuon of CD4 +  8 + cells. Thus, signal transduction through CD3 may result 
m entirely different cellular responses, depending on the stage of thymocyte  differentiation. These 
results suggest an involvement of CD3 as a hnk m signal transduction for at least two different 
decision points m the development  of a thymocyte. 
T 
he T lymphocyte lineage is generated from precommitted 
bone marrow-derived precursor cells that home to the 
thymus where they enter into a complex developmental pro- 
gram of sequential gene expression and TCR gene rearrange- 
ments. Early events include expression of the heat-stable an- 
tigen  (HSA) 1 (1), followed  by  the  ol  chain  of the  IL-2 
receptor (IL-2Ro  0 (2, 3). TCR-B chain rearrangement also 
takes place at this early stage of thymocyte  development. Com- 
pletion of the rearrangement of the B locus is indicated by 
the appearance of full-length/~ mRNA and is accompanied 
by loss of IL-2Rc~ and expression of small amounts of CD4 
and CD8 (4, 5). Strong evidence exasts that rearrangement 
of the B locus is critical for the transition to the stage charac- 
terized by expression of CD4 and CD8 and loss of IL-2Rc~ 
1Abbrewaons used In tfits  paper DN, double-negative,  DP, double-posture, 
FCM, flow cytometry, FTOC, fetal thymlc organ culture, HSA, heat- 
stable antigen,  IC, mtracellular, S, surface 
(6-8). This transition does not take place unless m the pres- 
ence of an intact thymic environment (9). The actual differen- 
uation signals required for further maturation at this impor- 
tant control point in thymocyte  development are unknown. 
The CD4b81~  -  thymocytes will then mature into 
the CD4 +8 + double-positive (DP) stage (10). The TCR-c~ 
genes complete their rearrangement at tbas stage, the ol~/CD3- 
TCR is expressed on the cell surface and selection events may 
now occur. Those thymocytes  possessing a TCR that is able 
to interact with self-MHC are rescued from cell death, a pro- 
cess called positive selection. Negative selection involves de- 
leuon of self-reacting  thymocytes by means  of apoptosis 
(11-13). The small percentage of cells that survive positive 
and negative selectmn increase their TCR expression, lose 
HSA,  and  develop into  mature CD4 +  single-positive  or 
CD8 + single-positive T  cells. 
In vivo and in v~tro, negative selection of DP thymocytes 
can be induced by antibodies directed against the TCR. For 
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to fetal thymic organ cultures (FTOC) can cause deletion of 
DP TCR + cells by apoptosis (14). However, we and others 
found that deletion of DP cells by anti-CD3 mAb treatment 
of FTOC is dependent on the time point of addition (15). 
In this study, we show that deletion takes place upon delayed 
addition, but not upon immediate addition of anti-CD3 mAb 
to day 14 FTOC.  In contrast, early addition of anti-CD3 
mAb induces accelerated transition of CD4- 8- IL-2R + cells 
to  the  CD4 +8 +  IL-2R-  stage,  and  blocks  TCR45  chain 
production. These data suggest that signaling through CD3, 
probably complexed with TCIk-~ chain, regulates transiuon 
of CD4-8-IL-2R + cells to the DP stage possibly associated 
with cessation of TCR-B chain gene rearrangement. In addi- 
tion, our data suggest that during development CD3e can 
be expressed on the cell surface of thymocytes in the absence 
of the TCR-B chain. 
Materials and Methods 
Mzce.  Newborn mice and 14-d pregnant  female BALB/c and 
C.B.-17 SCID mice were obtained from our own specific  pathogen- 
free breeding  faclhty. 
rnA~  Anu-TCR.-B chain antibody H57-597 (16), anu-TCR-~ 
chain antibody GL-3 (17), and antx-CD3e antibody 145-2Cll  (18), 
all hamster IgG; and antl-IL-2tkc~  annbody 5A2 (19) and anu-PGP-1 
antibody IM7 (20), both rat IgG, were isolated from culture super- 
natants by affinity chromatography over protein A columns (Phar- 
macla, Frelburg, FRG)  Purified antl-CD3e antibody 500A2 was 
purchased from Pharmmgen (San Diego, CA). Flow cytometry em- 
ployed  labeled anu-Lyt-2 (53 6-7), anti-L3T4 (RM-4-5), antl-TCR-~ 
(H57-597), antl-CD3e (145-2Cll), antl-TClk-6  (GL-3)  (all purchased 
from Pharmmgen), and fluorescenated antl-II~21kc~ anubody 5A2, 
using a FACScan  |  flow cytometer (Becton  Dlckmson & Co., Heidel- 
berg,  FRG) 
FTOC.  Fetal  thymlc lobes were prepared from BALB/c mice 
at day 14 ofgestauon They were cultured for various time periods 
on filter discs floating on I ml of IMDM supplemented w~th 10% 
selected FCS, 1% glutamm, and 1% kanamycm m 12-well dishes 
(Costar Corp, Cambridge, MA) at 37~  in 7% CO2/alr, similar 
to the method ofJenkmson et al. (21), as prewously described (22) 
When lobes were cultured  with anubo&es, the lobes were sus- 
pended for 2 h m medium supplemented with anu-CD3 mAb (145- 
2Cll if not otherwise stated) or antl-TCE-~ mAb, and thereafter 
placed on filter discs floating on the same medium unul analysis 
Exposure to antibo&es was started e~ther at the begmnmg of cul- 
ture or after various time intervals, as indicated with each experi- 
ment  If not otherwise  stated, cultured were terminated on day 
9 for analysis. Addmon of irrelevant hamster IgG to FTOC at 100 
/~g/ml did not show any effect on a/~ T cell development com- 
pared to FTOC grown m medium without antibo&es  Therefore, 
control lobes were treated in the same way using medium w~thout 
antibody Smgle cell suspensions were prepared and incubated for 
6-8 h at 37~  to allow shedding of bound antibodies (23) 
Flow Cytometry  Two-  and three-color stammgs were performed 
using FITC-, PE-, and biotin-labeled antibodies. As a third color, 
Tncolor-con3ugated  Streptavidm (Medac, Hamburg,  FKG) was 
used  Intracellular  stamings were performed  as described (24), 
modified to allow two-color combmed lntraceUular (IC) and sur- 
face (S) stammgs. First, thymocytes were incubated with FITC- 
labeled antibodies as indicated above. After washing, unlabeled an- 
ubodles of the same kind as used for staining the IC antigen were 
added to block binding of the labeled anubodles to structures ex- 
pressed on the cell surface  After incubation and washing, 75 #1 
of 0.5% saponin (Sigma Immunochemlcals, Delsenhofen, FRG) 
m PBS/FCS was added together with the PE- or biotin-labeled 
second anubody. All the following washing steps were performed 
m 0.1% saponm m PBS/FCS. PE-conjugated Streptavtdm  was added 
together with 75/~1 of 0.5% sapomn m PBS/FCS to detect biotin- 
labeled anubodles. Cell suspensions were washed three umes be- 
fore analysis Efficiency  of blocking by the unlabeled anubody was 
tested by permeabdlzmg  the cell membrane before adding  the 
blocking antibody followed  by the labeled antibodies Because  treat- 
ment with saponm made dlstmcuon of viable cells from dead cells 
on the basis of cell size or propldmm lo&de uptake impossible, 
Tricolor-con3ugated Streptawdm was used as a dead cell marker 
We found that Tricolor-conjugated Streptavldm specifically  pene- 
trates into dead cells and remains m these cells ~rrevembly  through 
many subsequent washing steps (Levelt, C  N, and K. Elchmann, 
manuscript  m preparation) 
Northern Blot Analym.  FTOC were cultured for 9 d m the ab- 
sence or presence of 100 ~g/ml anti CD3 mAb. Cells were isolated 
and total RNA was prepared as described (25), except that the pro- 
tease &gesuon step was omitted  Samples were denaturated in the 
presence  of  ethldmm bromide. RNA gels were prepared as described 
(26)  After electrophoresls, gels were photographed and RNA was 
transferred to membranes (Nylon Hybond, Amersham Interna- 
tional, Braunschwetg, FRG) and hybn&zed to 32p-labeled probes 
specific for C/~1 and Co~ (both a kind gaft of Dr. H. U  Weltzlen, 
Max Planck Insutut fur Immunblologle)  Because  low ENA yields 
were expected, quanufication was performed by subsequer.t hybnd- 
lzauon with probes specific for o~-actm (27) 
Mobdizat~on of lntracellular Free Calcium.  Calcmm moblhzanon 
studies were performed as described  by Rabmowtch et al  (28).  Cells 
were isolated from thymuses derived from embryos of day 16 gesta- 
uonal age. Thymocytes (5  x  106/ml) were loaded with Indo-1 by 
mcubauon with its acetoxy-methyl ester (Molecular Probes Inc, 
Eugene, OR) (5.3 M) and 0 027% pluromc amd (Molecular Probes 
Inc ) for 45 mm at 37~  The cells were washed and stained with 
PE-labeled antl-CD4 mAb and anti-CD8 mAb, FITC-labeled antv 
TCR-B mAb and anu-TClk-8 mAb at 4~  Cells  were washed and 
resuspended in  IMDM  supplemented  with  1%o  FCS  and  1% 
glutamm  Analysis followed immediately and was performed on 
a FACSstar  |  flow cytometer (Becton Dickinson & Co )  Concen- 
trauons of 50/~g/ml of antl-CD3 mAb and antl-TCR-8 mAb (both 
hamster IgG) were used for acuvauon 
Results 
Early Addition  of Anti-CD3  mAb to FTOC Inhibits  TCR 
Expression on CD4 +  8 + DP Thymocytes.  Thymic lobes from 
day 14 embryos were cultured for 9 d and analyzed by flow 
cytometry. 100/~g/ml of either anti-CD3 mAb or anti-TCR-B 
chain mAb were added to the cultures at day 0 or 6 of cul- 
ture.  Representauve absolute cell numbers recovered from 
FTOC treated in this way are given in Table 1. A triple-staining 
experiment monitoring expression of CD4 and CD8 and of 
TCR-fl chain within the CD4+8 + population upon anti- 
body treatment on day 6 is shown in Fig.  I, A-F. Both anti- 
bodies induce partial deletion of the TCR expressing DP 
subset.  As  described earlier,  the  anti-CD3  mAb  has  the 
stronger deleting capacity (29). Fig. 1, G-J shows the effects 
of the addition of the same antibodies on day 0. Under these 
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Percent total 
Anu-TCR-fl  Anti-CD3  AntI-TCR-/~  Antl-CD3 
Thymocyte subset  Control  Day 0  Day 0  Day 6  Day 6 
CD4+CD8 §  45 2  28 8  41 9  33.0  16 4 
CD4+CD8+VflS +  20.4  4 1  1 7  3 8  2 6 
CD4+VflIC -  11.0  7 0  48.8  9.9  3.5 
CD8+VBIC -  12 0  8 9  53 0  9 5  5.6 
V/~S-V/~IC  +  37.7  54.3  5.6  42.0  30.1 
CD3S-CD3IC +  41.6  57 2  79.6  45.5  54.5 
Absolute cell number 
per lobe ( x l0  s)  1 9  0.9  1 7  0 8  1 0 
proporttons of different thymocyte  subsets upon antibody  treatment of FTOC gaven m percentage of total FTOC were treated at 0 or day 6 of 
culture with antlbo&es to TCR-B or CD3  Control FTOC were cultured m medium without antlbo&es Cells were analyzed  by FCM on day 
9 of culture In&cated  are uncorrected percentages 
conditions treatment with antl-TCR-/~ mAb also &minishes 
the CD4+8+V/3 § subset.  In contrast, treatment with antl- 
CD3 mAb does not change the proportion of DP cells but 
leads to disappearance of  TCR expression in this population. 
Expression of lntracellular TCR-~ Chain in Thymocyte Sub- 
populations.  The results described above could be interpreted 
either as modulation of the TCR-B chain from the cell sur- 
face or as downregulatlon of the production of the/~ chain. 
To distinguish between these possibilities,  it was necessary 
to analyze the expression  of the B chain by FACS  |  analysis 
employing intracellular stalnings. To this end, we established 
several reformative staining protocols to analyze mtracellular 
expression of the B chain m thymocyte subsets of untreated 
organ cultures and in thymuses derived from newborn mice. 
Depicted m Fig. 2 A is a representative experiment analyzing 
the expression  of lntracellular/~ chain (V/~IC) and extracel- 
lular CD4 in thymocytes derived from FTOC after 9 d of 
culture. The vast  majority of CD4 § cells (of which most 
are DP) show lntracellular/~ chain. It is not dear whether 
the  small  group  of CD4 +  VBIC-  cells  are  m  fact inef~- 
ciently stained or really devoid of intracellular/~ chain. The 
CD4-V~/IC + population consists of mature CD8 § and im- 
mature  CD4-8-  double-negative (DN)  cells.  Analogous 
results were obtained by staining for CD8 instead of CD4. 
TCK-~/chain is detected already within TCR.-  cells (Fig. 
2 C). Upon surface expression,  the concentration of intracel- 
lular/~ chain drops slightly. In thymocytes derived from ex 
VlVO newborn thymus, we find a similar expression of intra- 
cellular B chain in the different subsets  (Fig.  2, B and D) 
Differences are only found in the proportions of the popula- 
tions. Intracellular CD3 is found m 85-95%  of all thymo- 
cytes. As seen for TCR-/3 chain, the concentration of lntra- 
cellular CD3 drops upon surface expression of the TCR (data 
not shown). 
Early Addition of Anti-CD3  mAb to FTOC Leads to Loss 
oflntracellular~ Chain.  Organ cultures treated at day 0 with 
100 #g/ml of mAb were examined, and representative original 
results are given in Fig. 3. In Table 1, the calculated propor- 
tions of the most prominent thymocyte subsets are summa- 
rized.  Anti-TCK-/~  treatment leads  to  decreased  numbers 
of CD4 + (Fig.  3,  A  and B)  and CD8 §  cells (see Fig.  1). 
Whereas the propomons of calls expressing TCR on the sur- 
face (V/~S) is strongly diminished (Fig. 3, D and E), intracel- 
lular B chain expression  is not affected by the anti-TCK-B 
treatment. This is shown by the unchanged ratios of V~IC + 
to V/3IC- cells within the CD4 + population (Fig. 3, A  and 
B) and within the V/3S-  population (Fig. 3, D and E) sur- 
viving the anti-TCK-~ treatment. In contrast, the antl-CD3 
mAb induces a decrease of intracellular ~  chain in all sub- 
populations.  It  is  surprising  that  even  the  VflS-VBIC § 
subset is strongly &tarnished, implying that calls on which 
no surface TCK is detected by flow cytometry are affected 
by anti-CD3 mAb. IntraceUular CD3 expression remains un- 
changed,  accounting  for  the  increase  in  the  CD3S- 
CD3IC +  subset  (Table  1).  Similar  results  were  obtained 
upon treatment of FTOC with the mAb 500A2, a mAb that 
binds to a different epitope of the CD3e chain (30).  This 
excludes the possibility that the effects observed  are due to 
erossreactivity of one antl-CD3e mAb with an unknown struc- 
ture on thymocytes. Table 1 also summarizes thymocyte  subsets 
determined by the same protocols upon adding the antibodies 
to day 6 of culture. Under these conditions, both anti-TCK-~ 
and antl-CD3 antibodies induce deletion of the TCK + DP 
population, as described above. 
Dose-Response Kineacs of the  Effect of Anti-CD3  Anti- 
bodies.  Optimal downregulation of TCK-~ chain was ob- 
tained by 100/zg/ml of anti-CD3 mAb, a rather high con- 
centration of roAb. We were therefore worried that nonspecific 
709  Levelt  et al Figure  1.  Effect of addmon of antl-TCR mAb to FTOC  Antibodies 
to TCR-~ (C, D, G, H) or CD3e (E, F, I,J) were added at a concentra- 
tion of 100/~g/ml to FTOC at day 6 (C-F) or day 0 (G-J) of culture 
Control FTOC were cultured without antibody (/1, B)  Cells were ana- 
lyzed by thee-color  flow cytometry (FCM)  at day 9  Contour plots  (A, 
C, E, G,/) represent CD4 and CD8 fluorescence mtensmes  Histograms 
(B, D, F, H, J) represent TCR-~ chain fluorescence intensity of CD4 +  8 + 
cells The numbers given m each panel represent uncorrected  percentages 
Background  values were mslgmficant  m  all cases 
effects  of Ig or the small degree of dilution  of the culture 
media contributed to the effect. We therefore tested a series 
of other Igs at  100/~g/ml,  including  normal  hamster IgG, 
normal rat IgG, anti-IL-2Ro~ (rat IgG), anti-TCR-~ (hamster 
IgG),  and anti-PGP-1  (rat IgG).  None of these resulted m 
the disappearance of TCR-~ chain m  DP thymocytes (data 
not shown). Furthermore,  a dose-response analysis was per- 
formed, using concentrations of anti-CD3  mAb between 1 
and 100 #g/ml (Fig.  4). We observe a nearly linear relation- 
ship  between  the  antibody  dose  and  the  sizes  of  the 
VBIC-CD8 + and V~IC-CD4 § populations.  We have also 
determined, m a different protocol, the degree of saturation 
of CD3 epltopes by these antibody concentrations.  Satura- 
tion is reached between 30 and 100 #g/ml. We conclude that 
anti-CD3  mAb is effective at  all concentrations,  the  max- 
lmal response being reduced at doses that  saturate all avail- 
able CD3e molecules. 
Time Course of  B Chain Shut.down by Anti-CD3 mAt~  The 
almost complete loss of intracellular ~ chain in all cell popu- 
lations suggested that the shut-down of B chain production 
by hgatlon  of CD3  takes place before or at the onset of 
chain expression  To study this question, we performed time 
course experiments, adding the antibody at different days of 
culture and examining the lobes at day 9. In Fig. 5 we show 
that addition up to day 2 (7 d before analysis) results m con- 
stant proportions of CD4 + and CD8 + cells devoid of intra- 
cellular ~/chain  Thereafter, B chain shut-down m CD4 +8 + 
cells  decreases  and is gradually replaced by a deletional  re- 
sponse until day 6. This indicates that shut-down of B chain 
is inducible until 6-7 d before the thymocytes leave the DP 
stage, which is at the CD4-8-Ib2E + stage,  as can be de- 
duced from the kinetics studies performed by Pearse et al. (4). 
Predominance of Short (1.0 kb) TCR-~ Chain Transc@ts in 
Anti-CD3 mAb Treated  FTOC.  We examined expression of 
TCR-cx and -~ genes by Northern blot analysis  (Fig.  6). A 
significant difference in TCR-B mRNA is observed between 
anti-CD3 treated and control FTOC. In the control FTOC, 
the full-length 1.3-kb (VDJC) transcript of the TCR-~ genes 
is clearly detectable, together with very low amounts of the 
truncated  1.0-kb (JC or DJC) message. In contrast,  m antl- 
CD3 treated cultures we see a dramatic reduction of the full- 
length  B mRNA  and  strongly increased expression of the 
truncated transcript.  If~ chain shut-down occurred by tran- 
scriptional downregulation we would expect a reduction in 
full-length mRNA and an unchanged or slightly decreased 
expression of truncated mRNA. The increased level of trun- 
cated ~  mRNA suggests that interruption  of ~  chain rear- 
rangement before V-D joining is the cause of B chain shut- 
down. Hybridization with the Cc~ probe showed full-length 
(VJC)  1.6-kb c~ gene transcripts  in antl-CD3  mAb treated 
and control cultures. A short, 1.3-kb (JC) transcript is barely 
detectable.  Since hybridization with a ol-actin probe indicated 
about 2.5 times more mRNA in the antl-CD3 mAb treated 
FTOC, TCE-o~ chain mRNA appears to be diminished.  We 
do not know whether this corresponds to expenmental vari- 
ation or reflects a downregulation of c~ chain transcription, 
possibly caused by the mahlity  to express the o~ chain  on 
the cell surface.  Because we do not find a predominance  of 
the truncated c~ chain transcript in the antl-CD3 mAb treated 
FTOC,  we do not expect rearrangement  of the o~ locus to 
be inhibited. 
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Figure  2.  Expression  of mtracellular  TCR-~ chain  m  thymocytes 
Thymocytes  derived from day 9 FTOC (A, C) and newborn thymus (B, 
D) were analyzed by FCM  Contour plots represent fluorescence intensity 
of mtracellular  TCR-B chain (V~3IC)  and extracellular  CD4 (A, B) and 
TCR-B (VBS) chain  (C, D)  Uncorrected percentages  are rod:cared 
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Figure  4.  Dose-response  kmeucs of the effect ofantvCD3 ant~bo&es 
AntvCD3 ant~bo&es were added to FTOC at day 0 of culture at concen- 
trations ranging from 1 to 100 ~g/ml  Expression of mtracellular TCR-~ 
chain and extracellular CD4 and CD8 were e~mmed by FCM  The per- 
centages of VBIC § (closed symbols) and V~IC- (open s~rabols) cells m the 
CD4 § population  (c~rdes) and m the CD8 § populauon (t~gles)  were 
calculated and are represented  as relatwe  propomons (percent  control) 
Expression of CD4 and CD8 and Loss of IL2R Is Induced 
by Anti-CD3  mA~  To  investigate  the  time  required for 
blocking ~  chain expression, antibo&es were added at day 
0 of culture and analyses were performed at short time in- 
tervals thereafter. The data m Fig. 7 reveal that mtracellular 
B chain is normally found before CD8 (Fig.  7, E and C), 
and confirm that CD4 appears after CD8 (Fig  7, A and E). 
Fig. 7, B and F show that already after 2 d of culture in the 
presence of anu-CD3 mAb we find reduced numbers of cells 
with intracellular B chain. Th~s includes the population that 
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Figure  3.  Effect of early addmon of antl-TCR antlbodxes to FTOC on 
mtracellular TCR-~ chain expression FTOC were cultured for 9 d m normal 
medmm (A, D) or medmm containing 100/~g/ml antlbo&es  to TCR-B 
chain  (B, E) or CD3e (C, F)  Cells were analyzed by FCM  Depicted 
are fluorescence mtensmes  of mtracellular TCR-B chain and extracellular 
CD4 (A-C) and TCR-B chain (D-F)  Uncorrected percentages are m&cated 
does not express CD4 and CD8. Moreover, the antibody treat- 
ment results in accelerated reduction of CD4 and CD8 (Fig. 
7, B, D, F, and/-/). In another experiment we included the 
analysis of IL-2Ro~ cham m addition to CD4 and CD8 (Fig 
8).  We find that accelerated acqmsltion  of CD4 and CD8 
is accompanied by downregulatlon  of II~2Rol chain expres- 
sion. Because downregulation of IL-2RoL seemed only shghtly 
accelerated compared to control FTOC, the results could be 
due to exper|mental variation. Therefore we repeated the ex- 
periment using FTOC derived from SCID mice, in which 
development  is  blocked  at  the  IL-2Rc~  ~  stage. Slgnahng 
through CD3 is expected to restore the blocked maturation 
instead of only accelerating normal development. Over 60% 
of thymocytes derived from untreated SCID-FTOC express 
Ib2Rc~  (Fig. 9 A). The population  showing a low surface 
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Figure  5.  Tn'ne course of shut-down of TCR-~ productzon  30/~g/ml 
antibodies  to TCR-3 (closed symbols),  CD3e (crossed symbols)  were added 
to FTOC at days 0-6 of culture  Control FTOC were cultured without 
antlbo&es (open symbols)  Cells were analyzed at day 9 of culture by FCM 
Represented are the percentages of V~IC- cells m the CD4 § populauon 
(squares) and CD8 + population (czrcles) 
711  Levelt et al Figure 6.  Northern blot analysts of TCK-c~  and -B mRNA from ann- 
CD3 treated and control.FTOC  FTOC were treated w~th 100 #g/ml 
antvCD3 annbo&es at day 0, and cells were harvested at day 9 of culture 
ILNA was prepared from  -5  x  106 cells and hybn&zed w~th probes 
specific for Co~ (A) and CB1 (B)  For quanttficatmn, the membranes were 
hybn&zed w:th ~-actm probes  (small boxes) By scanmng on an LKB 
Ultras:an XI. (LKB, Cambridge, UK) we detected -2 5 ttmes more RNA 
m the ann-CD3 treated group as compared w~th the control  The 1 6-kb 
band detected by the Ca probe represents fully rearranged (VJC) ot tran- 
scripts  The 1 3-kb band detected by the C/~1 probe represents the com- 
plete (VDJC) B mRNA, whereas the short transcnpts (1 0 kb) denve from 
incompletely rearranged B loc~ (DJC  or JC) 
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Figure 8.  Downregulanon  of IL-2  receptor c~ chain (Ib2R~) upon ann- 
CD3 treatment of FTOC  FTOC were treated wtth 100/~g/ml ann-CD3 
antxbo&es at day 0 of culture (B, D) or cultured wlthout annbndles (A, 
C) and analyzed by FCM at day 2 (A, B) and 3 (C,/9) of culture  Histo- 
grams show the fluorescence  intensity  of Ib21Lm Percentages  of cells  gated 
posture for II.r2RO~  are given m the figures. Mean fluorescence channds 
of posture cells were 145(A), 88 (B), 127 (C),  and 92 (D) 
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Figure 7.  Shut-down of TCR-B prnductton and mducnon of CD4 and CD8 upon ann-CD3 treatment of FTOC  FTOC were treated with 30 
/~g/ml ann-CD3 annbo&es at day 0 of culture (B, D, F, H) or cultured without anttbo&es (.4,  C, E, G)  Analysis by FCM was performed at day 
2 (.4, B, E, F) and day 3 (C, D, G,/4) of culture  Represented are fluorescence mtensmes of surface CD4 (A-D) and CD8 (E-H) and mtracellular 
TCR-B  Uncorrected  percentages are m&cated 
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Figure 9.  Downreguhuon of I1..2 receptor ,v chain (IL-2R~) upon ann, 
CD3 treatment of FTOC derived from SCID mice  FTOC derived from 
SCID embryos were treated with 100 #g/ml anu-CD3 anubodles  at day 
0 of culture (B) or cultured without antlbo&es (.4) and analyzed by FCM 
at day 6 of'culture.  Histograms  show the fluorescence intensity of IIs2Ro~ 
Percentages of cells gated posmve for Ib2Rol are gaven m the figures Back- 
ground values were <1% 
expression of Ib2Rc~ is also found in the recombmase activa- 
tion gene (RAG)-2-deficient mouse (8). Treatment with antl- 
CD3 mAb indeed leads to an almost complete loss of IL-2Rc~ 
expression (Fig. 9 B). These results reveal that/3 chain shut- 
down is not the only consequence of early ligation of CD3e 
in thymocytes.  Rather,  a complete developmental program 
is initiated which reflects the maturation steps typically ob- 
served upon  the acquisition  of the DP stage. 
Calcium Mobiliza,on  Can Be Induced by An,-CD3 mAb m 
Day 16 Embryonic DN TCR-  Thymocytes.  It Is generally 
accepted that small concentrations of CD3 may be detected 
on the surface of thymocytes as soon as CD8 is expressed 
(31).  If we assume that our findings are induced by a direct 
interaction between the antibody and the affected cell, CD3 
can transduce a signal even before expression of CD8. To test 
this hypothesis,  we analyzed the capabihty of DN TCR- 
cells derived from ex wvo thymuses from 16-d-old embryos 
to mobihze CF + upon hgation of CD3  The data depicted 
m  Fig.  10,  C  and D  show that  indeed Ca  z + can be mobv 
hzed in 15% of these cells. The response was, however, weaker 
and shorter than described for mature T cells (32). Thus far, 
we have no xnformauon on whether the immature thymocytes 
that respond to anti-CD3 mAb with Ca  2  § mobilization are 
identical with those that respond by 3 chain shut-down. An- 
tibodies to TCR-3,/# did not induce Ca  2  + mobilization m 
this cell population  (Fig.  10, A  and B), excluding that  the 
response is nonspeclfically reduced by a high concentrauon 
of hamster IgG. These results suggest that CD3e is expressed 
at  low  levels  m  a  proportion  of DN  TCR-  immature 
thymocytes and represents  a functional component  in  sig- 
naling events leading to transition from the DN to the DP 
stage￿9 
Discussion 
Although the developmental sequence of the phenotypes 
of thymocytes is well described, little is known about the 
molecular events that drwe these cells into each subsequent 
stage of maturation￿9 An important control point m thymic 
development  is  the  transiuon  of CD4-8-IL-2R +  thymo- 
cytes to the CD4+8+IL-2R -  stage. Several reports show that 
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Figure  10.  Calcmm  mob~hza- 
uon reduced by anu-CD3 anuboches 
m  DN TCR-  cells. Thymocytes 
s00  were isolated from embryos of day 
16 gestauonai  age and loaded with 
Indo-1  Subsequently, the cells were 
stained for CD4, CD8, TCR-B and 
-6 using antlbo&es free of azlde at 
4~  Gating was for cells negative 
for all markers.  Cells were sumu- 
lated  at  time  0  (arrow) wxth  50 
~g/ml antlboches to CD3 (C, D) 
or TCR-$ (.4, B) A and C gave the 
course  of  the  vaolet/blue  ratio, 
which *s hnear  to the mohmty of 
mobdxzed mtracelhlar Ca  2+, over 
tune B and D show the percentage 
a0o  of cells exposing a concentration of 
mtracellular  Ca  2  + above the back- 
ground level over time successful rearrangement and expression of the TCR-B chain 
plays  a critical role in this process.  Some years  ago it was 
shown that in SCID mice transgemc for a rearranged TCR- 
locus,  thymocytes  regained  the  ability  to  enter  the 
CD4 + 8 + stage (6). However, normal numbers of DP cells 
were only found in SCID mice transgenic for both rearranged 
ot and ~  loci.  Recent results demonstrated  that  disrupuon 
of eithor RAG-1  (7)  or RAG-2 (8) blocks development at 
the CD4-8-IL-2R + stage.  An arrest in thymocyte develop- 
ment  at this point is also found in mice with  a disrupted 
TCIk-B locus, in which the very small numbers of CD4 +  8 + 
cells are suspected to belong to the 3'/~ lineage.  (P. Mom- 
baerts,  personal  communication).  Mice devoid of TCR-c~ 
chain, m contrast, show normal numbers of DP thymocytes 
(33)  From these experiments it can be deduced that the com- 
plete rearrangement of the B locus is an important prerequi- 
site for further maturation of the ot/~ lineage.  This finding 
cannot be attributed to lntracellular events alone, because the 
transplantation of normal bone marrow cells into SCID mice 
gave rise to both donor-derived TCR + thymocytes and host- 
derived CD4 § 8 +  TCR-  SCID thymocytes (34). Recent ex- 
periments show that immature thymocytes may express a TCR 
complex consisting of/3-B homodimers in association with 
CD3. A TCIk complex consisting of a B-/~ chain homodimer, 
weakly assocaated with CD3, was detected by Punt et al. (35) 
on  a  transformed  CD4-8 +  thymocyte.  A  TCIk  complex 
consisting of a B-~ homodimer, tightly bound to CD3~ and 
CD3e,  but weakly associated with  CD3~" and CD33' was 
found on SCID T  cell lines  transfected with  a rearranged 
TCR-~ locus (36). It has been suggested that signals gener- 
ated upon surface expression of this complex induces the ex- 
pression of the coreceptors CD4 and CD8 and possibly also 
leads to allehc  exclusion,  an event that is a consequence of 
an interruption  of TCR-~  chain  rearrangement  (37) 
Our findings  show that most known events associated with 
the acquisition of the DP stage can be induced by early treat- 
ment of FTOC with anti-CD3e  mAb"  CD4 and CD8 ex- 
pression is induced  on DN  thymocytes.  Ib2Rot chain ex- 
pression is downregulated;  the cells fail to produce TCR-B 
chain.  The inhibition  of the production of TCIk-/~ protein 
and of full-length TCR-/~ mRNA by antl-CD3 may be caused 
by the same process that, m the physlologacal situation, results 
in allelic exclusion, i.e., interrupted rearrangement of TCIk-/~ 
genes. These findings support the hypothesis that surface ex- 
pression of and subsequent signal transduction through CD3, 
perhaps complexed with the TCIk-B chain,  may be an im- 
portant event directing the CD4-8-Ib2R + thymocytes into 
the next developmental stage. It is not dear, however, whether 
all of these pheno0rpic changes are part of a single cellular 
response or just happen  to occur simultaneously. 
Alternative  explanations  for shut-off of TCR-/5 produc- 
tion have to be considered. Our findings may reflect a novel 
kind of negative selection involving transcriptional  down- 
regulation of TCR-B chain production. Our time course ex- 
periments suggest that the window for inhibition of TCIk-B 
chain production is open during the CD4-8-IL-2R + stage 
and may be closed before the TCR-ot locus has  fully rear- 
ranged (38). Both a purpose and a pathway for self-tolerance 
induction at this stage of development are hard to imagane. 
Furthermore,  the mcreased expression of truncated (1.0 kb) 
TCR-B message is not easily reconciled with a transcriptional 
shut-off of TCR-~ production  Therefore, we favor the hy- 
pothesis that a cessation of rearrangement is the cause of im- 
paired  TCIk-/3  cham  production.  Rearrangement  of  the 
TCR-ot locus seems unimpaired  as can be concluded from 
the  Northern  blot  analysis  showing  full-length  TCR-c~ 
mRNA.  This is in line with recent experiments indicating 
that allelic exclusion of the TCR-c~ locus takes place at the 
DP stage and is dependent  on positive selection (39). 
How could rearrangement  of the TCIk-~ chain genes be 
interrupted by hgation of CD3? Owen et al.  (15) who ob- 
served reduced  numbers  of Vfl8IC + cells  without  reduc- 
tion of CD4 + and CD8 + cells upon antl-CD3 treatment of 
FTOC, suggested that 3'/~ cells were necessary for rearrange- 
ment of the TCR-B locus and that their function was blocked 
by anti-CD3 mAb. This can be ruled out because recent ex- 
periments  show that  TCR-~-deficient  mice can neverthe- 
less rearrange the B locus (P. Mombaerts, personal commu- 
nication).  It is also possible that antl-CD3 antibodies block 
the interaction of an unknown hgand with CD3 which is 
required for/~ chain rearrangement  to continue to comple- 
tion. This possibility is unlikely because the blocking of an 
essential maturanon  signal would be expected to result m 
decreased maturation to DP cells. In our experiments, m con- 
trast,  accelerated maturation  to the DP stage is observed. 
We therefore favor the hypothesis that a signal which m 
the physiological situation is transduced by CD3 complexed 
with the B-/~ homodlmer, is delivered prematurely upon h- 
gation of CD3~ molecules before rearrangement of the B locus 
has finished.  This implies that CD3e molecules are expressed 
on the cell surface of immature  thymocytes in the absence 
of the TCR-/~ chain and are capable of signal transductlon 
upon crosshnking.  This hypothesis is supported by our finding 
that reduction of CD4 and CD8 and downregulation of IL- 
2Rc~ can be induced in FTOC from SCID mice upon anti- 
CD3 antibody treatment  (manuscript m preparation)  The 
characterization of a thymocyte expressing CD3 on the cell 
surface in the absence of TCR-ot-, ~-, qr-, or -~ chains (40), 
and the recent finding that B-/~ homodlmers are expressed 
on immature thymocytes (35, 36) suggest that the assembly 
and surface expression of the TCR complex is differently 
regulated at early stages of thymocyte development and sup- 
port the hypothesis that surface expression of a partial TCR 
complex is important  for thymocyte maturation. 
Our Ca  2+ mobilization experiments show that a cons,d- 
erable  number  (15%)  of DN  TCIk-  thymocytes derived 
from embryonic day 16 thymus in fact express functional 
CD3.  It remains to be investigated what the exact pheno- 
type of these cells is. The population appears to be too large 
to represent immature 3'/c5 cells expressing undetectable con- 
centrations of TCR. Because TCR-c~ message is barely de- 
tectable at embryonic day 16 (41), the population is also too 
large to represent  a subset of thymocytes that  has success- 
fully rearranged both the ot and 3 locus and express still un- 
714  Induction of Thymocyte Development through CD3 detectable concentrations of TCR. Therefore, we propose 
that at least part of ths population is DN thymocytes ex- 
pressing some CD3 with or without a TCR-/~ chain. 
It is interesting how the physiological signals  for shut- 
down of/3 gene rearrangement are generated. A signal may 
be generated upon formation within the thymocyte mem- 
brane of a complex of CD3 with B'/~ homodxmers and per- 
haps additional molecules. Alternauvely, this complex in- 
teracts with a ligand on other cells in the thymus, of  epithelial 
or hematopoetic origin. This latter hypothes~s  is attractive 
because it provides an explanation for the exclusive localiza- 
tion of T  cell development to the thymus. 
Taken together, these expertments demonstrate that matu- 
ration of DN to DP cells,  which appears to be dependent 
on fl chain rearrangement, is a developmental step inducible 
by signaling through CD3. In addition, the results suggest 
that  CD3e  is  expressed on the cell surface of developing 
thymocytes in the absence of a TCR-fl chain. Analysis of 
the molecular structure of this putative CD3 complex may 
be of major importance m the understanding of the very early 
stages  of thymocyte development. 
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